Float Short %

7.11

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.14

EPS Last/This Y

0.32

EPS This/Next Y

0.1

Price

2.69

Target Price

7.08

Analyst Recom

1.57

Performance Q

15.95

Relative Volume

0.88

Beta

2.55

Ticker: CDXS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	CDXS	2.77	0.07	0.00	924
2025-07-07	CDXS	2.59	0.05	0.40	1117
2025-07-08	CDXS	2.67	0.05	0.40	1117
2025-07-09	CDXS	2.91	0.06	0.00	1124
2025-07-10	CDXS	3.12	0.06	0.00	1075
2025-07-11	CDXS	2.99	0.05	0.00	1345
2025-07-14	CDXS	3.08	0.05	0.00	1358
2025-07-15	CDXS	2.81	0.05	0.00	1357
2025-07-16	CDXS	2.86	0.05	0.00	1360
2025-07-17	CDXS	2.88	0.05	0.00	1360
2025-07-18	CDXS	2.81	0.05	0.00	1361
2025-07-21	CDXS	2.85	0.01	0.00	1317
2025-07-22	CDXS	3.05	0.01	0.00	1308
2025-07-23	CDXS	3.32	0.01	0.63	1388
2025-07-24	CDXS	3.23	0.05	0.08	1503
2025-07-25	CDXS	3.12	0.05	0.00	1557
2025-07-28	CDXS	3.04	0.05	0.05	1565
2025-07-29	CDXS	2.83	0.05	1.14	1607
2025-07-30	CDXS	2.79	0.05	1.50	1609
2025-07-31	CDXS	2.66	0.06	0.00	1629
2025-08-01	CDXS	2.68	0.06	0.00	1628
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	CDXS	2.77	52.5	-	-0.56
2025-07-07	CDXS	2.59	52.5	-	-0.56
2025-07-08	CDXS	2.67	52.5	-	-0.56
2025-07-09	CDXS	2.91	52.5	-	-0.56
2025-07-10	CDXS	3.11	52.5	-	-0.56
2025-07-11	CDXS	2.99	52.5	-	-0.56
2025-07-14	CDXS	3.08	52.5	-	-0.56
2025-07-15	CDXS	2.81	52.5	-	-0.56
2025-07-16	CDXS	2.86	52.5	-	-0.56
2025-07-17	CDXS	2.88	52.5	-	-0.56
2025-07-18	CDXS	2.81	52.5	-	-0.56
2025-07-21	CDXS	2.84	52.5	-	-0.56
2025-07-22	CDXS	3.05	52.5	-	-0.56
2025-07-23	CDXS	3.33	52.5	-	-0.56
2025-07-24	CDXS	3.24	52.5	-	-0.56
2025-07-25	CDXS	3.11	52.5	-	-0.56
2025-07-28	CDXS	3.05	52.5	-	-0.56
2025-07-29	CDXS	2.82	52.5	-	-0.56
2025-07-30	CDXS	2.79	52.5	-	-0.56
2025-07-31	CDXS	2.68	52.5	-	-0.56
2025-08-01	CDXS	2.69	52.5	-	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	CDXS	140.25	7.29	7.93
2025-07-07	CDXS	140.25	7.29	7.93
2025-07-08	CDXS	140.25	7.29	7.93
2025-07-09	CDXS	140.25	7.29	7.93
2025-07-10	CDXS	140.25	7.29	7.93
2025-07-11	CDXS	140.25	7.29	8.85
2025-07-14	CDXS	140.25	7.64	8.85
2025-07-15	CDXS	140.25	7.64	8.85
2025-07-16	CDXS	140.25	7.64	8.85
2025-07-17	CDXS	140.25	7.64	8.85
2025-07-18	CDXS	140.25	7.64	8.85
2025-07-21	CDXS	140.25	5.88	8.85
2025-07-22	CDXS	143.99	5.88	8.85
2025-07-23	CDXS	143.99	5.88	8.85
2025-07-24	CDXS	143.99	5.88	8.85
2025-07-25	CDXS	143.99	5.88	7.11
2025-07-28	CDXS	143.99	6.10	7.11
2025-07-29	CDXS	143.99	6.10	7.11
2025-07-30	CDXS	143.99	6.10	7.11
2025-07-31	CDXS	144.36	6.10	7.11
2025-08-01	CDXS	141.93	6.10	7.11
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

141.93

Institutional Transactions

6.1

Beta

2.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.6

Max Drawdown 5-Year %

-96.4

Target Price

7.08

P/E

Forward P/E

PEG

P/S

4.47

P/B

4.49

P/Free Cash Flow

EPS

-0.99

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

-0.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-149.47

Relative Volume

0.88

Return on Equity vs Sector %

-173.8

Return on Equity vs Industry %

-155.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 188

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y